These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 35411483)

  • 1. Deep Brain Stimulation for Addictive Disorders-Where Are We Now?
    Yuen J; Kouzani AZ; Berk M; Tye SJ; Rusheen AE; Blaha CD; Bennet KE; Lee KH; Shin H; Kim JH; Oh Y
    Neurotherapeutics; 2022 Jul; 19(4):1193-1215. PubMed ID: 35411483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep brain stimulation for the treatment of drug addiction.
    Wang TR; Moosa S; Dallapiazza RF; Elias WJ; Lynch WJ
    Neurosurg Focus; 2018 Aug; 45(2):E11. PubMed ID: 30064320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleus Accumbens as a Novel Target for Deep Brain Stimulation in the Treatment of Addiction: A Hypothesis on the Neurochemical and Morphological Basis.
    Vannemreddy P; Slavin K
    Neurol India; 2019; 67(5):1220-1224. PubMed ID: 31744946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Deep brain stimulation in the context of addiction--a literature-based systematic evaluation].
    Bauer R; Pohl S; Klosterkötter J; Kuhn J
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):396-401. PubMed ID: 18604773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep brain stimulation in addiction: a review of potential brain targets.
    Luigjes J; van den Brink W; Feenstra M; van den Munckhof P; Schuurman PR; Schippers R; Mazaheri A; De Vries TJ; Denys D
    Mol Psychiatry; 2012 Jun; 17(6):572-83. PubMed ID: 21931318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nucleus accumbens and alcoholism: a target for deep brain stimulation.
    Ho AL; Salib AN; Pendharkar AV; Sussman ES; Giardino WJ; Halpern CH
    Neurosurg Focus; 2018 Aug; 45(2):E12. PubMed ID: 30064314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation surgery for alcohol addiction.
    Voges J; Müller U; Bogerts B; Münte T; Heinze HJ
    World Neurosurg; 2013; 80(3-4):S28.e21-31. PubMed ID: 22824557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleus accumbens deep brain stimulation results in insula and prefrontal activation: a large animal FMRI study.
    Knight EJ; Min HK; Hwang SC; Marsh MP; Paek S; Kim I; Felmlee JP; Abulseoud OA; Bennet KE; Frye MA; Lee KH
    PLoS One; 2013; 8(2):e56640. PubMed ID: 23441210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action.
    Pierce RC; Vassoler FM
    Psychopharmacology (Berl); 2013 Oct; 229(3):487-91. PubMed ID: 23907650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleus accumbens as a stereotactic target for the treatment of addictions in humans: a literature review.
    Sobstyl M; Kupryjaniuk A; Mierzejewski P
    Neurol Neurochir Pol; 2021; 55(5):440-449. PubMed ID: 34633060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of deep brain stimulation of the nucleus accumbens in morbid obesity.
    Oterdoom DLM; van Dijk G; Verhagen MHP; Jiawan VCR; Drost G; Emous M; van Beek AP; van Dijk JMC
    Neurosurg Focus; 2018 Aug; 45(2):E10. PubMed ID: 30064329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of deep brain stimulation surgery for substance use disorder: a systematic review.
    Hassan O; Phan S; Wiecks N; Joaquin C; Bondarenko V
    Neurosurg Rev; 2021 Aug; 44(4):1967-1976. PubMed ID: 33037538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic unilateral stimulation of the nucleus accumbens at high or low frequencies attenuates relapse to cocaine seeking in an animal model.
    Hamilton J; Lee J; Canales JJ
    Brain Stimul; 2015; 8(1):57-63. PubMed ID: 25457212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent bilateral deep brain stimulation of the nucleus accumbens shell reduces intravenous methamphetamine intake and seeking in Wistar rats.
    Batra V; Tran TL; Caputo J; Guerin GF; Goeders NE; Wilden J
    J Neurosurg; 2017 Apr; 126(4):1339-1350. PubMed ID: 27392268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep brain stimulation of the nucleus accumbens shell increases impulsive behavior and tissue levels of dopamine and serotonin.
    Sesia T; Bulthuis V; Tan S; Lim LW; Vlamings R; Blokland A; Steinbusch HW; Sharp T; Visser-Vandewalle V; Temel Y
    Exp Neurol; 2010 Oct; 225(2):302-9. PubMed ID: 20615406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-frequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in vivo.
    McCracken CB; Grace AA
    J Neurosci; 2007 Nov; 27(46):12601-10. PubMed ID: 18003839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to closed-loop deep brain stimulation for movement disorders.
    Kuo CH; White-Dzuro GA; Ko AL
    Neurosurg Focus; 2018 Aug; 45(2):E2. PubMed ID: 30064321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility clinical trial of nucleus accumbens deep brain stimulation for treatment-refractory opioid use disorder.
    Rezai AR; Mahoney JJ; Ranjan M; Haut MW; Zheng W; Lander LR; Berry JH; Farmer DL; Marton JL; Tirumalai P; Mears A; Thompson-Lake DGY; Finomore VS; D'Haese PF; Aklin WM; George DT; Corrigan JD; Hodder SL
    J Neurosurg; 2024 Jan; 140(1):231-239. PubMed ID: 37329519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications.
    Dandekar MP; Fenoy AJ; Carvalho AF; Soares JC; Quevedo J
    Mol Psychiatry; 2018 May; 23(5):1094-1112. PubMed ID: 29483673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.